EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pruritus in Uremic Patients: Approaches to Alleviating a Common Symptom in Chronic Kidney Disease

Ștefania Cîrstea iD, Olguța Anca Orzan iD, Diana Silvia Zilișteanu

Life · 24.06.2025 · 15 (7) · 1001

DOI: 10.3390/life15071001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 24.06.2025. Verfasst von Ștefania Cîrstea und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease-associated pruritus (CKD-aP) is a distressing symptom that affects both dialysis and non-dialysis patients, significantly impairing their quality of life. Despite its multifactorial pathophysiology, no gold-standard treatment has been established. This review explores various therapeutic options and evaluates their effectiveness based on recent clinical studies and meta-analyses. Therapies targeting novel mechanisms have evolved in recent years. Difelikefalin, a κ-opioid receptor agonist, represents a breakthrough in systemic treatment, demonstrating efficacy with a favorable safety profile. Another opioid-based therapy, nalfurafine, has shown notable symptom relief in multiple clinical studies, with a low risk of abuse. Sertraline, an antidepressant, offers another alternative, although its delayed onset remains a limitation. Nonpharmacologic approaches are also evolving. Phototherapy, particularly UV-B therapy, modulates the immune response, reduces inflammation, and effectively alleviates itching in hemodialysis patients. Personalized treatment strategies are crucial, as responses vary among patients. Further research, including comparative and long-term studies, is essential to refine treatment algorithms and improve patient outcomes. By integrating new pharmacologic and nonpharmacologic options, CKD-aP management is shifting toward a more tailored and effective approach that addresses the individual needs of each patient.

Schlagwörter

Stichwörter der Autor:innen

chronic kidney diseasepruritusuremic patienturemic pruritus

Autor:innen und Institutionen

  • Faculty of Medicine, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.
  • Department of Allergology, Nicolae Malaxa Clinical Hospital, 022441 Bucharest, Romania.
  • Department of Dermatology, 'Elias' University Emergency Hospital, 011461 Bucharest, Romania.
  • Nephrology Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.

ORCID-Profile: Ștefania Cîrstea, Olguța Anca Orzan

Zitieren

APA

Cîrstea, Ș., Orzan, O. A., & Zilișteanu, D. S. (2025). Pruritus in Uremic Patients: Approaches to Alleviating a Common Symptom in Chronic Kidney Disease. Life, 15(7), 1001. https://doi.org/10.3390/life15071001

Vancouver

Cîrstea Ș, Orzan OA, Zilișteanu DS. Pruritus in Uremic Patients: Approaches to Alleviating a Common Symptom in Chronic Kidney Disease. Life. 2025;15(7):1001. doi:10.3390/life15071001

BibTeX
@article{Crstea2025,
  author = {Cîrstea, Ștefania and Orzan, Olguța Anca and Zilișteanu, Diana Silvia},
  title = {Pruritus in Uremic Patients: Approaches to Alleviating a Common Symptom in Chronic Kidney Disease},
  journal = {Life},
  year = {2025},
  volume = {15},
  number = {7},
  pages = {1001},
  doi = {10.3390/life15071001}
}
Kostenlos starten →